RU94019425A - DERIVATIVES OF IZATINOKSIMA, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT - Google Patents

DERIVATIVES OF IZATINOKSIMA, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT

Info

Publication number
RU94019425A
RU94019425A RU94019425/04A RU94019425A RU94019425A RU 94019425 A RU94019425 A RU 94019425A RU 94019425/04 A RU94019425/04 A RU 94019425/04A RU 94019425 A RU94019425 A RU 94019425A RU 94019425 A RU94019425 A RU 94019425A
Authority
RU
Russia
Prior art keywords
cyclic
branched
alkyl
izatinoksima
derivatives
Prior art date
Application number
RU94019425/04A
Other languages
Russian (ru)
Other versions
RU2114827C1 (en
Inventor
Ватьен Франк
Хуго Дахль Вьярне
Драйер Йорген
Хелт Йенсен Лейф
Original Assignee
Неуросеарч А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неуросеарч А/С filed Critical Неуросеарч А/С
Publication of RU94019425A publication Critical patent/RU94019425A/en
Application granted granted Critical
Publication of RU2114827C1 publication Critical patent/RU2114827C1/en

Links

Claims (1)

Описываются соединения, имеющие формулу
Figure 00000001

где R4 и R5 независимо представляют собой водород, галоген CF3, CN, NO2 или группу SO2NR1R2, где R1 - водород или C1-6 алкил, который может быть разветвленным или циклическим, R2 - водород или C1-6 алкил, который может быть нормальным, разветвленным или циклическим, или где R1 или R2 вместе образуют группу -(CH2)n-A-(CH2)m-, где A - 0, S, CH2 или NRI, где RI -H, C1-6 алкил, который может быть нормальным, разветвленным или циклическим, n = 0, 1, 2, 3, 4, 5; m = 0, 1, 2, 3, 4, 5; Q - NOH или 0; Z = 0, S, N - RII,
Figure 00000002
NRIV-C(O)-NRV-,
Figure 00000003
где RII, RIII, RIV и RV независимо представляют собой водород, бензил, C1-6 ацил, C1 -6-алкоксил, который может быть разветвленным или циклическим, или C1-6 алкил, который может быть разветвленным или циклическим; X представляет -(CH2)o-, где о = 0, 1, 2 или 3; Y представляет -(CH2)p-, где p - 0, 1, 2 или 3; α и β указывают точки присоединения; способ лечения заболеваний млекопитающих, человека, связанных с блокадой рецепторов глутаминовой и аспарагиновой кислоты, с помощью этих соединений.
Describes compounds having the formula
Figure 00000001

where R 4 and R 5 independently represent hydrogen, halogen CF 3 , CN, NO 2 or a group of SO 2 NR 1 R 2 , where R 1 is hydrogen or C 1 - 6 alkyl, which may be branched or cyclic, R 2 - hydrogen or C 1 - 6 alkyl, which may be normal, branched or cyclic, or where R 1 or R 2 together form the group - (CH 2 ) n - A - (CH 2 ) m -, where A - 0, S, CH 2 or NR I , where R I is H, C 1 is 6 alkyl, which can be normal, branched or cyclic, n = 0, 1, 2, 3, 4, 5; m = 0, 1, 2, 3, 4, 5; Q is NOH or 0; Z = 0, S, N - R I I ,
Figure 00000002
NR I V -C (O) -NR V -,
Figure 00000003
where R I I , R I I I , R I V and R V independently represent hydrogen, benzyl, C 1 - 6 acyl, C 1 - 6 alkoxy, which may be branched or cyclic, or C 1 - 6 alkyl, which may be branched or cyclic; X is - (CH 2 ) o -, where o = 0, 1, 2 or 3; Y is - (CH 2 ) p -, where p is 0, 1, 2 or 3; α and β indicate points of attachment; A method of treating diseases of mammals, human, associated with the blockade of glutamic and aspartic acid receptors, with the help of these compounds.
RU94019425/04A 1991-08-28 1992-08-27 Isatine or isatine oxime derivatives, method of synthesis of isatine oxime and a pharmaceutical composition RU2114827C1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US75116591A 1991-08-28 1991-08-28
US751,165 1991-08-28
US751165 1991-08-28
US83185192A 1992-02-05 1992-02-05
US831,851 1992-02-05
US831851 1992-02-05

Publications (2)

Publication Number Publication Date
RU94019425A true RU94019425A (en) 1995-09-27
RU2114827C1 RU2114827C1 (en) 1998-07-10

Family

ID=27115380

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94019425/04A RU2114827C1 (en) 1991-08-28 1992-08-27 Isatine or isatine oxime derivatives, method of synthesis of isatine oxime and a pharmaceutical composition

Country Status (18)

Country Link
EP (1) EP0529636B1 (en)
JP (1) JP3170584B2 (en)
KR (1) KR100277481B1 (en)
AT (1) ATE181552T1 (en)
AU (1) AU655672B2 (en)
CA (1) CA2076948C (en)
CZ (1) CZ282759B6 (en)
DE (1) DE69229461T2 (en)
DK (1) DK0529636T3 (en)
FI (1) FI107156B (en)
GE (1) GEP20002329B (en)
HU (2) HUT70753A (en)
MX (1) MX9204914A (en)
NO (1) NO301117B1 (en)
PL (1) PL170920B1 (en)
RU (1) RU2114827C1 (en)
SK (1) SK280578B6 (en)
WO (1) WO1993005043A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994009000A1 (en) 1992-10-13 1994-04-28 Warner-Lambert Company Quinoxalinedione derivatives as eaa antagonists
WO1994026747A1 (en) * 1993-05-13 1994-11-24 Neurosearch A/S Ampa antagonists and a method of treatment therewith
US5843945A (en) * 1993-05-13 1998-12-01 Neurosearch A/S AMPA antagonists and a method of treatment
DK81593D0 (en) * 1993-07-07 1993-07-07 Neurosearch As NEW ISATIN OXIMIZE DERIVATIVES, THEIR PREPARATION AND USE
AU686888B2 (en) * 1994-09-14 1998-02-12 Neurosearch A/S Fused indole and quinoxaline derivatives, their preparation and use
JP3164371B2 (en) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ Indole-2,3-dione-3-oxime derivatives, their production and use
UA54403C2 (en) 1996-10-01 2003-03-17 Н'Юросерч А/С indole-2,3-dione-3-oxime derivatives, A PHARMACEUTICAL COMPOSITION, A METHOD FOR TREATING DISORDER OR DISEASE OF MAMMALS INCLUDING A MAN, AND A METHOD FOR PREPARATION OF Indole-2,3-dione-3-oxime derivatives
FR2768624B1 (en) 1997-09-25 1999-11-12 Oreal USE OF AN EXCITING AMINO ACID INHIBITOR IN A COSMETIC OR DERMATOLOGICAL COMPOSITION FOR SENSITIVE SKIN AND COMPOSITION OBTAINED
WO2000071102A2 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
EP1736468A3 (en) 2000-01-24 2007-01-03 NeuroSearch A/S Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation
AU2003273114A1 (en) 2002-10-29 2004-05-25 Sungkyunkwan University Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
BRPI0618863A2 (en) 2005-11-23 2016-09-13 Painceptor Pharma Corp methods of modulating the activity of a dependent ion channel and treating pain, a disorder associated with the genitourinary or gastrointestinal systems in an individual, and
EP2935213B1 (en) * 2012-12-19 2019-05-22 Bayer CropScience Aktiengesellschaft Difluoromethyl-nicotinic-indanyl carboxamides as fungicides
US9815768B2 (en) * 2014-02-28 2017-11-14 Sumitomo Chemical Company, Limited Method for producing 2-(halogenomethyl)-3-methylnitrobenzene
EA039557B1 (en) 2016-03-17 2022-02-10 Фмк Корпорейшн Process for converting s-enantiomer to its racemic form
CN112266367B (en) * 2017-11-15 2023-12-08 中山光禾医疗科技有限公司 Preparation, raw materials, products and application of photocrosslinked hydrogel material
CN108912127B (en) * 2018-08-27 2019-12-10 青岛农业大学 Benzo [ b, e ] azepine compound based on isatin skeleton and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use

Similar Documents

Publication Publication Date Title
RU94019425A (en) DERIVATIVES OF IZATINOKSIMA, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT
RU93005057A (en) PHARMACEUTICAL COMPOUNDS, THYENOBENZODIAZEPINE DERIVATIVES, METHOD FOR THEIR PRODUCTION, PHARMOCOMPOSITION AND THEIR USE
LV10860A (en) Saturation of phenylalkylamine
EP0285287A3 (en) 3-benzazepine compounds for use in treating gastrointestinal motility disorders
KR910002802A (en) Derivatives of 1,2,3,4-tetrahydro-9-acridinamine
HUT70753A (en) Isatinoxime derivatives, process for preparing them and pharmaceutical compositions containing them
ATE79257T1 (en) USE OF TETRAHYDROBENZENE(C,D>INDOL-6CARBOXAMIDES IN THE MANUFACTURE OF PHARMACEUTICALS FOR THE TREATMENT OF ANXIETY CONDITIONS.
DE69104314T2 (en) Use of 1- [3- (dimethylamino) propyl] -1-phenylphthalenes for the treatment of cerebrovascular disorders.
KR890011596A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for treating insomnia
NO885346L (en) PROCEDURE FOR THE PREPARATION OF ARYLOXYPHENYL PROPYLAMINES
FI94354C (en) Method for preparing pharmaceutically active peptides
ES539123A0 (en) A COMPOUND OF 3-INDOLCARBOXAMIDE
ATE99934T1 (en) HETEROARYL-3-OXO-PROPANNITRILE DERIVATIVES USEFUL IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISEASES.
KR880001596A (en) Dihydropyridine Compound-containing Brain Dysfunction
DE68900516D1 (en) THERAPEUTIC AGENTS FOR TREATING STOMACH.
RU2001113272A (en) 3-Tetrahydropyridine-4-ylindoles for the treatment of psychotic disorders
ES2035915T3 (en) ANTIARRHYTHMIC AGENTS N-FENETIL-AMINOALQUIL-BENZAMIDA.
GR3002267T3 (en) Dissymmetrical 1,4-dihydropyridine-3,5-dicarboxylic-acid derivatives, preparation processes and therapeutical use
SE8802428D0 (en) NEW COMPOUNDS
FR2647785B1 (en) NOVEL PYRROLIDONE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE69214205D1 (en) New isatine oxime derivatives, their production and use
ATE198750T1 (en) ISATINOXIM DERIVATIVES, THEIR PREPARATION AND USE
DE3650311D1 (en) Use of quinazolines for the manufacture of a medicament for the treatment and prevention of arrhythmia.
KR880000383A (en) 1,7-substituted heptin-2-one and its use in the treatment of neurological bladder disease
DE3782229D1 (en) USE OF 2-OXO-IMIDAZOLIDINE DERIVATIVES FOR THE TREATMENT OF KIDNEY DISEASES.